Back to top

Citi adds ‘upside 30-day catalyst watch’ on GoodRx

Citi analyst Daniel Grosslight added an “upside 30-day catalyst watch” on GoodRx (GDRX) while keeping a Buy rating on the shares with a $4 price ta...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GoodRx Holdings, Inc. (GDRX)